SUMMARY The prevalence of mitral valve prolapse was investigated in 126 patients with hyperthyroidism due to Graves' disease or toxic nodular goitre and that of hyperthyroidism in 64 patients with mitral valve prolapse. One hundred and eleven asymptomatic healthy subjects comprised a control group. The patients with hyperthyroidism were divided into those with Graves' disease and those with toxic nodular goitre. Of the group as whole, 12 (9 5%) patients had mitral valve prolapse compared with six (5-4%) in the control group, but the difference was not statistically significant. Accepted for publication 20 November 1984 large numbers of hyperthyroid patients did not indicate such a high prevalence. We therefore decided to investigate a large population drawn from our endocrine and cardiological institutes in order to determine the prevalence of hyperthyroidism in patients with mitral valve prolapse.
Since the first description by Barlow in 1963 of mitral valve prolapse, numerous reports have been published. ' 2 The prevalence of the condition appears to be increasing partly owing to increased clinical awareness and partly to the increased use of-echocardiography, and figures between 1% and 21% have been reported in otherwise normal populations.-6 Medical opinion of the clinical importance of mitral valve prolapse also varies. It ranges from being considered to have a poor prognosis owing to a high rate of arrhythmias and endocarditis7 8 to being considered as a normal anatomical variation of the mitral valve apparatus.9 Mitral valve prolapse has been reported associated with disorders such as Marfan's syndrome,'0 osteogenesis imperfecta, "I and others.' 2 13 The prognosis is influenced by the causation of the mitral valve prolapse. Primary prolapse generally has a good prognosis while secondary prolapse, especially when due to occlusive coronary disease, is more seri-OUS. 14 Accepted for publication 20 November 1984 large numbers of hyperthyroid patients did not indicate such a high prevalence. We therefore decided to investigate a large population drawn from our endocrine and cardiological institutes in order to determine the prevalence of hyperthyroidism in patients with mitral valve prolapse.
Patients and methods
Three groups of subjects were examined.
Group All the subjects in the three groups underwent thyroid function tests (total thyroxine (TT4) by radioimmunoassay, T3 resin uptake, free thyroxine index and both M mode and cross sectional echocardiography, which were performed on a Smith Kline Echoline 20A echocardiograph with recordings made on a VR12 instrument in both the parasternal long axis and apical four chamber views. The echocardiograms were read by two experienced echocardiographers without prior knowledge of the diagnosis. The criteria for the diagnosis of mitral valve prolapse were mid systolic buckling or pansystolic hammocking >3 mm below the C-D line on the M mode echocardiogram and protrusion of the mitral leaflets beyond the plane of the atrioventricular ring in the long axis view and prolapse of the leaflets beyond the mitral annulus in the four chamber view on the cross sectional echocardiogram.
Statistical analysis was performed with the x2 test. Graves' disease and mitral valve prolapse have some similarities, which could point to a common denominator. Graves' disease is seven times more common among women. The ratio of women to men with mitral valve prolapse in reported series varies from 1*4: 1 in one study'6 to 3: 1 in another.'7 In our series 79-6% of the patients with Graves' disease were women, and mitral valve prolapse was found in a ratio of 4: 1 in favour of women (Table 1) .
Results
Genetic factors have been identified in Graves' disease'8 and also in mitral valve prolapse. An incidence of mitral valve prolapse of 5O0/o in monozygotic twins has been reported.'920 The condition was also found in identical twins.2' The peak incidence of Graves' disease occurs during the third and fourth decades. Although seen in infancy,22 mitral valve prolapse becomes more evident in adult life, possibly owing to progressive myxomatous degeneration of the mitral valve apparatus as a consequence of ischaemic heart disease, connective tissue abnormalities, or trauma. ' Graves' disease is known to be associated with the major histocompatibility antigens Bw35, DRw3, and B8. 23 In patients with mitral valve prolapse some studies showed a higher prevalence of HLA-Bw35 (73% vs 390/o in controls), but only in American black subjects.24 Another study of predominantly white patients showed that the A3; Bw35 phenotype is quite specific for mitral valve prolapse.25 Nevertheless, in another study no HLA correlation was found in white subjects. 26 No ABO blood group specifity was found in American black subjects.24 Autoimmunity is a well known causative factor in Graves' disease,27 and recently it has been mentioned also in the aetiology of mitral valve prolapse. Miklozek et al and Schlant et al reported that 20 out of a total 40 patients with mitral valve prolapse had a positive antinuclear factor compared with only 4% in a matched control group.2829 Several manifestations usually seen in autoimmune connective tissue disorders (joint pains, rheumatic fever, hair loss, Raynaud's phenomenon, and pleuritis) were found in these patients.
For many years the cardiac manifestations of hyperthyroidism were thought to be mediated by catecholamines or hyperthyroidism to be associated with an increased adrenergic tone. 30 Aoki et al suggested that the cardiac effects of hyperthyroidism were due to the direct effect of thyroid hormones3' rather than induced by catecholamine hypersensitivity. On the other hand, Boudoulas et al found increased catecholamine concentrations and higher adrenergic tone in patients with mitral valve prolapse.32 In the present study the incidence of hyperBrauman, Algom, Gilboa, Ramot, Golik, Styjer thyroidism was negligible in a large group of patients with mitral valve prolapse, as found also by others. 33 Whatever the relation between these two disorders, therefore, it is probably not due to increased adrenergic tone.
In our study we confirmed the findings of Channick et al' 5 of a higher prevalence of mitral valve prolapse in patients with Graves' disease. Although the number of patients that we examined was larger, the proportion of patients with mitral valve prolapse was smaller but still significantly larger than that in euthyroid controls. Moreover, mitral valve prolapse was no more frequent in patients with toxic nodular goitre than in the controls. 
